Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb;9(2):60-69.
doi: 10.1159/000486292. Epub 2018 Jan 25.

Cerebral Cavernous Malformations: An Update on Prevalence, Molecular Genetic Analyses, and Genetic Counselling

Affiliations
Review

Cerebral Cavernous Malformations: An Update on Prevalence, Molecular Genetic Analyses, and Genetic Counselling

Stefanie Spiegler et al. Mol Syndromol. 2018 Feb.

Abstract

Based on the latest gnomAD dataset, the prevalence of symptomatic hereditary cerebral cavernous malformations (CCMs) prone to cause epileptic seizures and stroke-like symptoms was re-evaluated in this review and calculated to be 1:5,400-1:6,200. Furthermore, state-of-the-art molecular genetic analyses of the known CCM loci are described which reach an almost 100% mutation detection rate for familial CCMs if whole genome sequencing is performed for seemingly mutation-negative families. An update on the spectrum of CCM1, CCM2, and CCM3 mutations demonstrates that deep-intronic mutations and submicroscopic copy-number neutral genomic rearrangements are rare. Finally, this review points to current guidelines on genetic counselling, neuroimaging, medical as well as neurosurgical treatment and highlights the formation of active patient organizations in various countries.

Keywords: Cerebral cavernous malformations; Genetic counselling; Molecular genetics; Prevalence; Vascular malformation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
T1-weighted (A) and T2-weighted (B) MRI of a 25-year-old proband with a cavernous malformation in his left posterior parietal lobe (red arrows). The Zabramski type II CCM with a maximum diameter of 23 mm shows the typical popcorn-like appearance and mixed signal intensities. The surrounding dark rim in T1 and T2 imaging is due to hemosiderin deposits.
Fig. 2
Fig. 2
Spectrum and distribution of known mutations in CCM1, CCM2, and CCM3. The organization of the main transcripts is schematically depicted with blue boxes indicating protein coding exons, clear boxes representing non-coding exons, and blue lines indicating intronic sequences [exon numbering according to the locus reference genomic (LRG) database]. The last coding nucleotide of each exon is given below each box. Nonsense, frameshift, missense, and splice site mutations listed in HGMD 2017.2 are depicted in the upper part of each subpanel. Small deletions, insertions and indel variants that affect splicing have been classified as splice mutations. ATG, start codon; TGA, stop codon. Large deletions and insertions are not included.
Fig. 3
Fig. 3
Comprehensive genetic screening of CCM1–3 by targeted capture enrichment and NGS. A Representative diagnostic NGS data from our own cohort (unpublished data). The read depth across the coding regions of CCM2 is shown as coverage plot (dark blue); exon-intron structures of the ENSEMBL-listed CCM2 transcripts are shown below. A chromosome ideogram with the cytogenetic location of CCM2 (red line) is depicted in the upper part and the GC content is illustrated with CpG islands in the lower part. B Representative NGS-based CNV analysis demonstrating a heterozygous deletion of exon 8 and 9 of CCM3.

References

    1. Acuna-Hidalgo R, Bo T, Kwint MP, van de Vorst M, Pinelli M, et al. Post-zygotic point mutations are an underrecognized source of de novo genomic variation. Am J Hum Genet. 2015;97:67–74. - PMC - PubMed
    1. Akers A, Al-Shahi Salman R, A Awad I, Dahlem K, Flemming K, et al. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery. 2017;80:665–680. - PMC - PubMed
    1. Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet. 2009;18:919–930. - PMC - PubMed
    1. Al-Holou WN, O'Lynnger TM, Pandey AS, Gemmete JJ, Thompson BG, et al. Natural history and imaging prevalence of cavernous malformations in children and young adults. J Neurosurg Pediatr. 2012;9:198–205. - PubMed
    1. Al-Shahi Salman R, Hall JM, Horne MA, Moultrie F, Josephson CB, et al. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol. 2012;11:217–224. - PMC - PubMed